The Patterson Analysis

Pollo AI's new Commerce Studio promises to slash product visual costs for sellers. But as AI automates the photo shoot, it raises critical questions about creative jobs and consumer trust.

Stingray's revenue soars post-TuneIn, but a massive goodwill impairment leads to a net loss. We analyze the tension between aggressive growth and profitability.

Cliffwater's hire of Sean Brenan and launch of its Cascade Real Assets Fund is a calculated move to exploit market turmoil and democratize access to private assets.

As the quantum threat looms, SEALSQ joins leaders from defense, space, and energy at a key summit to forge a path for securing Europe's critical infrastructure.

The real estate marketplace iFinder enters San Antonio, betting its vetted-investor model can out-execute traditional cash buyers in a cooling market.

A new Philips report quantifies AI's benefits in healthcare, from saving time to catching errors. But the path to adoption is fraught with challenges.

A €2M EU grant is funding a Singapore-led initiative to turn wastewater into a high-tech early warning system for disease outbreaks across Asia.

Longpoint Partners is deploying €400M into Germany and the Netherlands. An analysis of whether this is a savvy play on market constraints or a risky bet.

A deep dive into how a pet-centric franchise is turning Pride month support into a tangible, localized, and executable business strategy.

As return-to-office mandates clash with the needs of 5 million Canadians with migraine, the economic toll of inaction is mounting for employers.

South Korea's Dong Bang Co Ltd is moving beyond commodity animal drugs, targeting high-barrier markets. Is its focus on proprietary tech a viable global strategy?

National Bank is raising $600M with complex notes offering a 6% yield. We dissect the deal, revealing the strategic gains and the risks investors must weigh.

As Parker Seminars plans its 2026 Dallas event, it's about more than tradition. It's a strategic convergence of chiropractic, neuroscience, and business.

Ottawa's new fund promises a new era of community building, but success hinges on execution, complex partnerships, and a clear path from pilot to production.

Fast Loan UK's new automated debt system promises a leap in efficiency. But as human oversight shrinks, it poses a critical test of regulatory and ethical limits.

With its new SYNMUE™ probiotic, SynbioTech is targeting the biological clock of our immune system. A deep dive into the science, the strategy, and the execution.

AM Best's stable outlook for Korea P&I isn't just a rating change. It's a validation of a tough, calculated strategy to reduce risk and leverage state support.

With 460,000 providers enrolled, Careviso is tackling healthcare's most hated process. A case study shows it's cutting case times by more than half.

An annual symposium celebrated Latina leaders, but beneath the surface lies a rigorous, data-driven engine for professional advancement. Here's the analysis.

As Finland races toward carbon neutrality, a new partnership shows how AI-driven batteries are becoming the backbone of a stable, renewable-powered grid.